Avanos Medical, Inc. provided earnings guidance for the year 2024. For the year, the Company anticipates revenue between $685 million and $705 million from continuing operations.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.39 USD | -0.15% | +4.14% | -9.09% |
May. 02 | Avanos Medical to Seek M&A Opportunities | CI |
May. 02 | Transcript : Avanos Medical, Inc., Q1 2024 Earnings Call, May 02, 2024 |
1st Jan change | Capi. | |
---|---|---|
-9.09% | 880M | |
-5.43% | 181B | |
+4.30% | 114B | |
-3.09% | 68.29B | |
+5.86% | 52.24B | |
+8.15% | 44.3B | |
+7.52% | 42.73B | |
+25.54% | 32.52B | |
+17.85% | 26.02B | |
+1.00% | 25.91B |
- Stock Market
- Equities
- AVNS Stock
- News Avanos Medical, Inc.
- Avanos Medical, Inc. Provides Earnings Guidance for the Year 2024